<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346875</article-id>
      <article-id pub-id-type="pmc">3876006</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132055</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Analysis of mutations in the PIK3CA and FGFR3 genes in verrucous
epidermal nevus<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>An&#xE1;lise de muta&#xE7;&#xF5;es nos genes PIK3CA e FGFR3 em
caso de nevo epid&#xE9;rmico verrucoso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Miranda</surname>
            <given-names>Ludmilla Queir&#xF3;s</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fracaroli</surname>
            <given-names>Tain&#xE1; Scalfoni</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fonseca</surname>
            <given-names>Jo&#xE3;o Carlos Macedo</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fontenelle</surname>
            <given-names>Elisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Curvo</surname>
            <given-names>Raphael Pedro Machado</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porto</surname>
            <given-names>Lu&#xED;s Crist&#xF3;v&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff06">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souto</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff07">7</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Dermatologist, private practice - Goi&#xE2;nia (GO), Brazil.</aff>
      <aff id="aff02"><label>2</label> Dermatologist, private practice - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label> PhD in Dermatology. Professor of Dermatology, Pedro Ernesto University
Hospital - (Hospital Universitario Pedro Hernesto - HUPE), University of the State of
Rio de Janeiro (Universidade do Estado do Rio de Janeiro - UERJ) - Rio de Janeiro (RJ),
Brazil.</aff>
      <aff id="aff04"><label>4</label> Dermatologist, Fernandes Figueira Institute (Instituto Fernandes
Figueira - IFF) - Oswaldo Cruz Foundation (Funda&#xE7;&#xE3;o Oswaldo Cruz -
Fiocruz) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff05"><label>5</label> PhD student of Experimental Human Biology. Researcher, Laboratory of
Histocompatibility and Cryopreservation - University of the State of Rio de Janeiro
(HLA-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff06"><label>6</label> PhD in Human Biology, Universit&#xE9; Claude Bernard Lyon I. Full
professor of Histology and Embryology, University of the State of Rio de Janeiro (UERJ).
Coordinator of the Laboratory of Histocompatibility and Cryopreservation - University of
the State of Rio de Janeiro (HLA-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff07"><label>7</label> MSc student of Dermatology. Preceptor, Dermatology Service, Pedro
Ernesto University Hospital - University of the State of Rio de Janeiro (HUPE-UERJ).
Researcher, Laboratory of Histocompatibility and Cryopreservation - University of the
State of Rio de Janeiro (HLA-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Ludmilla Queir&#xF3;s Miranda, Rua T-53, n 857 -
Setor Bueno, 74215-150 - Goi&#xE2;nia - GO, Brazil. E-mail:
<email>ludqmiranda@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>36</fpage>
      <lpage>38</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Verrucous epidermal nevi are congenital hamartomas composed of keratinocytes and may
occur alone or in association with developmental abnormalities. A close relationship
between variations in the PIK3CA and FGFR3 genes and the appearance of nevi has been
recently reported. Based on that, we performed molecular assays for the
identification of E542K, E545G/K and H1047R mutations in the PIK3CA gene and of the
R248C mutation in the FGFR3 gene. Interestingly, during the amplification process, we
did not observe the PCR product of exon 9 of the PIK3CA gene, a region comprising
amino acids 542-545. This strongly suggests the occurrence of a microdeletion of that
region and indicates a possible allelic variant, which has not yet being described in
the literature.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Os nevos epid&#xE9;rmicos verrucosos s&#xE3;o hamartomas cong&#xEA;nitos
compostos por queratin&#xF3;citos, que podem ocorrer isolados ou associados a
altera&#xE7;&#xF5;es do desenvolvimento. Com a recente observa&#xE7;&#xE3;o
de uma rela&#xE7;&#xE3;o estreita entre varia&#xE7;&#xF5;es nos genes PIK3CA
e FGFR3 e o aparecimento do nevo, realizamos ensaios moleculares para
identifica&#xE7;&#xE3;o das muta&#xE7;&#xF5;es E542K, E545G/K e H1047R do
gene PIK3CA, e R248C do gene FGFR3. Interessantemente, durante o processo de
amplifica&#xE7;&#xE3;o n&#xE3;o observamos o produto da PCR do exon 9 do gene
PIK3CA, regi&#xE3;o que compreende aos amino&#xE1;cidos 542-545, sugerindo
fortemente a ocorr&#xEA;ncia de uma microdele&#xE7;&#xE3;o da regi&#xE3;o e
indicando uma prov&#xE1;vel variante al&#xE9;lica ainda n&#xE3;o descrita na
literatura.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Hamartoma</kwd>
        <kwd>Mutation</kwd>
        <kwd>Nevus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Verrucous epidermal nevi are congenital hamartomas composed of keratinocytes and are
classified into epidermolytic and non-epidermolytic. Their prevalence in adults is 0.1
to 0.5%, and there is no predilection for gender or race.1 They are initially whitish
due to maceration by the amniotic fluid. Over time, they acquire the aspect of a velvety
streak or of a slightly brownish or pinkish plaque. The lesions are distributed
following the Blaschko lines; on the trunk, they tend not to cross the midline.</p>
      <p>In this report, we describe a verrucous nevus of the non-epidermolytic type, which
should be clinically differentiated from other epidermal nevi, for they are usually
present at birth, asymptomatic, non-inflammatory and persistent. </p>
      <p>Non-epidermolytic verrucous epidermal nevus may originate from different genetic
mutations, which have not yet been completely identified. Recent reports in the
literature point to a relation between the disease with the fibroblast growth factor
receptor 3 gene (<italic>FGFR3</italic>) and the phosphatidylinositol 3-kinase catalytic
subunit alpha (PIK3CA) oncogene.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r04">4</xref></sup> The mechanism of action of these variants
in the development of the disease and phenotypic level have not yet been elucidated;
however, such mutations have been described in almost half of cases and have a strong
association with oncogenesis.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Histopathology of non-epidermolytic verrucous epidermal nevus shows hyperkeratosis and
acanthosis, often associated with papillomatosis and occasionally with focal
hypergranulosis and parakeratosis. About 10% of lesions show the pattern of
acrokeratosis verruciformis and seborrheic keratosis. They rarely present histological
findings characteristic of viral warts, acanthosis nigricans or of the verrucous phase
of incontinentia pigmenti.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>A variety of developmental abnormalities may occur in association with verrucous
epidermal nevus. These abnormalities include localized anomalies such as megalopinna and
aplasia cutis of the scalp as well as syndromes such as epidermal nevus syndrome,
Proteus Syndrome, McCune-Albright Syndrome, and Klippel-Trenaunay Syndrome.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>The various treatment options, which are not always satisfactory, include topical
salicylic acid, retinoic acid, calcipotriol, and calcitriol,<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> cryotherapy for
smaller lesions, and systemic retinoids for bigger and unaesthetic lesions. Patients and
caregivers should understand that drug therapy is not curative and that relapses are
common when treatment is discontinued. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A three-year old black female patient from Rio de Janeiro presented with diffuse
hyperchromic macules which were present at birth and became darker and keratotic over
time. She was born by vaginal term delivery and presented psychomotor development
compatible with her age. Dermatological examination revealed presence of velvety
hyperchromic papules on the face, neck, trunk, and limbs (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>). Distribution of the
lesions follows the Blaschko lines in the posterior area of the trunk (<xref ref-type="fig" rid="f03">Figure 3</xref>). No other changes were observed on physical
examination. </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Brownish papules in linear arrangements with a velvety surface in the posterior
cervical region</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0036-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Hyperchromic verrucous lesions on the face, anterior trunk and upper limbs</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0036-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Lesions on the posterior trunk following the Blaschko lines</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0036-g03"/>
      </fig>
      <p>Histopathological examination of the cervical region showed hyperkeratosis, acanthosis,
and papillomatosis, which is compatible with verrucous nevus. Genetic analysis of
peripheral blood and of the skin lesion detected a mutation in the Aa542-545 region of
the PIK3CA gene, despite the aspect of deletion. Additional tests will be conducted for
clarification. For amplification of the Aa542-545 region, we used downstream
5'CCAGAGGGGAAAAATATGACAAAG3' and upstream 5'CCCTTTCATTTTTCTTTTTTCTTACG'3 primers at the
following final concentrations of reagents: 1x Buffer, MgCl2 2.5 mM, dNTPs 0.2mM,
primers 0.5&#xB5;M; polymerase 0.03 U/ &#xB5;L; Sample ~ 100ng. Thermocycling
conditions were 50&#xBA;C for 2 minutes; 95&#xBA;C for 10 minutes; 40 cycles of
95&#xBA;C for 30 seconds, 58&#xBA;C for 1 minute, 72&#xBA;C for 1 minute, and
72&#xBA;C for 10 minutes. </p>
      <p>The patient is being regularly monitored and using adapalene gel 0.1% on the face,
showing little response. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Classification of verrucous nevus into epidermolytic and non-epidermolytic is done by
histopathology. In the case here discussed, the absence of epidermolysis allowed us to
classify it as non-epidermolytic verrucous nevus. </p>
      <p>Some genetic mutations have been proposed to explain the origin of non-epidermolytic
verrucous nevi. The main ones are those in the PIK3CA oncogene and in the FGFR3 gene.
During the amplification phase for the discrimination of E542K, E545G/K and H1047R
mutations in the PIK3CA gene and the R248C mutation in the FGFR3 gene, we observed
absence of the polymerase chain reaction (PCR) product for exon 9 of the PIK3CA gene, a
region which corresponds to codons 542-545. The absence of amplification strongly
suggests the occurrence of a microdeletion of the region or a gene rearrangement, which
has not yet been described (<xref ref-type="fig" rid="f04">Figure 4</xref>). The main
function of the exon 9 region of the PIK3CA gene is a helical domain of interaction with
other proteins. As the absence of this region has not yet been reported, we can only
suggest that the interaction relationship between proteins of this pathway should be in
disequilibrium, which could be the primary cause of the disease. Another relevant datum,
in case this variant is confirmed, is the possibility that this allele is not correctly
identified in heterozygous individuals, since only one allele with the microdeletion
still allows amplification and observation of the PCR product and sequencing as a false
wild-type. Other mutations investigated for the PIK3CA and FGFR3 genes were not
identified. </p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Amplification products of the regions of the PIK3CA gene; Top line, investigation
of E542K, E545G or E545K mutations; Bottom line, investigation of H1047R mutation.
Columns from left to right: <bold>1)</bold> 100bp DNA Ladder
Invitrogen<sup>&#xAE;</sup>, <bold>2)</bold> Positive Control,
<bold>3)</bold> Patient of the study, <bold>4</bold> and <bold>5)</bold> Other
Patients, <bold>6)</bold> Negative Control</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0036-g04"/>
      </fig>
      <p>Despite the need for further molecular studies in order to characterize this mutation,
it is likely that this new allele will bring some relevant information about the
function of the PIK3CA protein and also contribute to a better understanding and
diagnosis of verrucous epidermal nevus.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work conducted at Pedro Ernesto University Hospital - University of the State of
Rio de Janeiro (Hospital Universitario Pedro Hernesto - Universidade do Estado do Rio
de Janeiro / HUPE-UERJ) - Rio de Janeiro (RJ) - Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interest: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Coulson</surname>
              <given-names>IH</given-names>
            </name>
          </person-group>
          <chapter-title>Systemic disease and the skin</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Burn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Breathnach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <source>Rook's textbook of dermatology</source>
          <edition>8 ed</edition>
          <publisher-loc>Singapore</publisher-loc>
          <publisher-name>Wiley-Blackwell</publisher-name>
          <year>2010</year>
          <fpage>62</fpage>
          <lpage>72</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hafner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>van Oers</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Vogt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Landthaler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stoehr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Blaszyk</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Mosaicism of activating FGFR3 mutations in human skin causes epidermal
nevi</article-title>
          <source>J Clin Invest</source>
          <year>2006</year>
          <volume>116</volume>
          <fpage>2201</fpage>
          <lpage>2207</lpage>
          <pub-id pub-id-type="pmid">16841094</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bygum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fagerberg</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Clemmensen</surname>
              <given-names>OJ</given-names>
            </name>
            <name>
              <surname>Fiebig</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hafner</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Systemic epidermal nevus with involvement of the oral mucosa due to
FGFR3 mutation</article-title>
          <source>BMC Med Genet</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>79</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="pmid">21639936</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hafner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-Knowles</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Luis</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Toll</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baselga</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Casado</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic
keratoses with a characteristic mutation pattern</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>13450</fpage>
          <lpage>13454</lpage>
          <pub-id pub-id-type="pmid">17673550</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engelman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>The evolution of phosphatidylinositol 3-kinases as regulators of
growth and metabolism</article-title>
          <source>Nat Rev Genet</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>606</fpage>
          <lpage>619</lpage>
          <pub-id pub-id-type="pmid">16847462</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gon</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Minelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Franzon</surname>
              <given-names>PGU</given-names>
            </name>
          </person-group>
          <article-title>Case for diagnosis. Inflammatory linear verrucous epidermal
nevus</article-title>
          <source>An Bras Dermatol</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>729</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="pmid">21152805</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
